THE PROMISE FOR PEOPLE WITH OBESITY ?

A novel medication, Retatrutide , is sparking considerable buzz amongst clinicians and people in Australia facing with weight challenges. Developed by Eli Lilly , Retatrutide works as a dual GIP and GLP-1 receptor agonist, showing significant potential to support weight loss and improve internal